
Phio Pharmaceuticals Corp.
PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31
Reports and events: 316 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-01-1417:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-20-000141 |
| 2020-01-1017:21 ET | 8-K | 5.07 Shareholder vote results | 0001683168-20-000082 |
| 2019-12-1807:30 ET | 8-K | 8.01 Other events | 0001683168-19-004008 |
| 2019-12-0617:15 ET | 8-K/A | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001683168-19-003908 |
| 2019-11-2217:22 ET | DEF 14A | Proxy statementPeriod 2019-12-12 | 0001683168-19-003804 |
| 2019-11-2021:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-19-003762 |
| 2019-11-1217:20 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001683168-19-003555 |
| 2019-11-1207:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-19-003527 |
| 2019-11-1207:31 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001683168-19-003526 |
| 2019-11-0817:12 ET | 8-K/A | 5.07 Shareholder vote results | 0001683168-19-003511 |
| 2019-10-2517:25 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001683168-19-003370 |
| 2019-10-0118:40 ET | S-1 | Registration statement | 0001683168-19-003116 |
| 2019-09-2517:07 ET | S-1/A | Registration statement, amended | 0001683168-19-003041 |
| 2019-08-3017:27 ET | S-1 | Registration statement | 0001683168-19-002795 |
| 2019-08-3017:27 ET | DEF 14A | Proxy statementPeriod 2019-08-22 | 0001683168-19-002796 |
| 2019-08-1217:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-19-002550 |
| 2019-08-1217:01 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001683168-19-002547 |
| 2019-08-0917:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-19-002524 |
| 2019-05-1417:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-19-001520 |
| 2019-05-1417:16 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001683168-19-001519 |
| 2019-03-2717:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-19-000798 |
| 2019-03-2717:11 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001683168-19-000795 |
| 2019-02-1517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-19-000423 |
| 2019-01-2817:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-19-000206 |
| 2018-12-2107:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-18-003773 |
| 2018-11-1917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-18-003505 |
| 2018-11-1407:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-18-003391 |
| 2018-11-1407:06 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001683168-18-003390 |
| 2018-11-1317:20 ET | 8-K | 3.01 Delisting notice | 0001683168-18-003381 |
| 2018-10-0517:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-18-002979 |
| 2018-09-2806:04 ET | S-1/A | Registration statement, amended | 0001683168-18-002882 |
| 2018-09-2608:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-18-002841 |
| 2018-09-1417:28 ET | S-1/A | Registration statement, amended | 0001683168-18-002758 |
| 2018-09-0407:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-18-002589 |
| 2018-08-3117:21 ET | S-1 | Registration statement | 0001683168-18-002585 |
| 2018-08-2109:25 ET | 8-K | 8.01 Other events | 0001683168-18-002438 |
| 2018-08-1409:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-18-002283 |
| 2018-08-1409:11 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001683168-18-002282 |
| 2018-06-0817:02 ET | 8-K | 5.07 Shareholder vote results | 0001683168-18-001640 |
| 2018-06-0117:16 ET | 8-K | 3.01 Delisting notice | 0001193125-18-181966 |
| 2018-05-1007:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-158336 |
| 2018-05-1007:07 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001193125-18-158327 |
| 2018-05-0917:22 ET | S-1 | Registration statement | 0001193125-18-157718 |
| 2018-04-2616:46 ET | DEF 14A | Proxy statementPeriod 2018-06-05 | 0001193125-18-135022 |
| 2018-04-1116:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-18-114322 |
| 2018-03-2917:16 ET | 8-K | 3.01 Delisting notice | 0001193125-18-102213 |
| 2018-03-2710:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-096928 |
| 2018-03-2616:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-096062 |
| 2018-03-2616:49 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001193125-18-096053 |
| 2018-03-2616:44 ET | 10-Q/A | Quarterly report, amendedPeriod 2017-09-30 | 0001193125-18-096031 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.